Genital Herpes: Transmission, First Outbreak & Antiviral Facts
A clinical guide to HSV-1 and HSV-2, asymptomatic viral shedding, suppressive therapy, and living stigma-free.
Clinical Review Standard
Reviewed by Dr. Jordan Hayes, MD, Infectious Disease Specialist. Grounded in consensus guidelines from CDC, WHO, NHS, and ACOG.
- Genital herpes is caused by HSV-1 (increasingly common via oral sex) or HSV-2.
- Over 85% of people with genital HSV are unaware they have it because symptoms are mild or absent.
- Transmission can occur even when no sores are present, through a phenomenon called asymptomatic viral shedding.
- Daily suppressive antiviral therapy (valacyclovir) reduces outbreaks by 70–80% and lowers partner transmission risk by nearly 50%.
1. HSV-1 vs. HSV-2: What's the Difference?
Historically, HSV-1 was considered 'oral herpes' (cold sores) and HSV-2 was 'genital herpes.' Today, because of common oral-genital contact, up to 50% of new genital herpes cases in young adults are caused by HSV-1.
2. The First Outbreak vs. Subsequent Outbreaks
The primary outbreak typically occurs 2 to 12 days after direct skin-to-skin exposure.
3. Asymptomatic Viral Shedding and Safer Sex
The virus periodically reactivates and sheds microscopic particles on the surface of genital skin even when no sores, redness, or symptoms exist.
Myths vs. Clinical Facts
Evidence: ACOG protocols manage herpes safely throughout pregnancy and delivery.
Frequently Asked Questions
How is herpes diagnosed accurately?
The gold standard is a PCR swab of an active blister or sore within 48 hours of appearance. Blood tests (type-specific IgG) can detect antibodies 12–16 weeks post-exposure.
When to Consult a Healthcare Professional
- • Painful genital sores or blisters appear.
- • Difficulty urinating due to severe genital burning.
- • Eye redness or pain during a suspected herpes outbreak (ocular herpes requires immediate emergency ophthalmologic care).
- CDC — Genital Herpes Detailed Fact Sheet
- World Health Organization (WHO) — Herpes Simplex Virus
- American Sexual Health Association (ASHA) — Herpes Resource Center
- New England Journal of Medicine — Valacyclovir Transmission Reduction Trial